Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_assertion type Assertion NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_head.
- NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_assertion wasGeneratedBy ECO_0000203 NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_provenance.
- NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_assertion wasDerivedFrom befree-20150227 NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_provenance.
- NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_assertion SIO_000772 24878056 NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_provenance.
- NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_assertion evidence source_evidence_literature NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_provenance.
- NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_assertion description "[Teprotumumab (RV 001, R1507) is a human monoclonal anti-IGF-1R blocking antibody currently undergoing a phase 2 clinical trial in patients with active TAO.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481856.RA-jWYMYqMweOfBftB054YL7YU7UE1jC3p7klWN52iAWc130_provenance.